Skip to main content
Explore URMC

Andrew D. Goodman, M.D.


Showing all 73 journal articles & 0 books available

Journal Articles

Lublin F, Miller DH, Freedman MS, Cree BA, Wolinsky JS, Weiner H, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BM, Merschhemke M, Li B, Putzki N, Liu FC, Häring DA, Kappos L, . "Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial." Lancet.. 2016 Mar 12; 387(10023):1075-1084. Epub 2016 Jan 28.

Applebee A, Goodman AD, Mayadev AS, Bethoux F, Goldman MD, Klingler M, Blight AR, Carrazana EJ. "Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial." Clinical therapeutics.. 2015 Dec 1; 37(12):2780-7. Epub 2015 Nov 10.

Goodman AD, Bethoux F, Brown TR, Schapiro RT, Cohen R, Marinucci LN, Henney HR, Blight AR, . "Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trials." Multiple sclerosis : clinical and laboratory research.. 2015 Sep; 21(10):1322-31. Epub 2015 Jan 12.

Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA, . "Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial." Lancet.. 2012 Nov 24; 380(9856):1829-39. Epub 2012 Nov 01.

Cohen JA, Coles AJ, Arnold DL, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Fisher E, Brinar VV, Giovannoni G, Stojanovic M, Ertik BI, Lake SL, Margolin DH, Panzara MA, Compston DA, . "Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial." Lancet.. 2012 Nov 24; 380(9856):1819-28. Epub 2012 Nov 01.

Kinkel RP, Dontchev M, Kollman C, Skaramagas TT, O'Connor PW, Simon JH, . "Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance." Archives of neurology.. 2012 Feb; 69(2):183-90. Epub 2011 Oct 10.

Samkoff LM, Goodman AD. "Symptomatic management in multiple sclerosis." Neurologic clinics.. 2011 May; 29(2):449-63.

Morrow SA, O'Connor PW, Polman CH, Goodman AD, Kappos L, Lublin FD, Rudick RA, Jurgensen S, Paes D, Forrestal F, Benedict RH. "Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks." Multiple sclerosis : clinical and laboratory research.. 2010 Nov; 16(11):1385-92. Epub 2010 Aug 25.

Goodman AD, Brown TR, Edwards KR, Krupp LB, Schapiro RT, Cohen R, Marinucci LN, Blight AR, . "A phase 3 trial of extended release oral dalfampridine in multiple sclerosis." Annals of neurology.. 2010 Oct; 68(4):494-502.

Rudick RA, O'Connor PW, Polman CH, Goodman AD, Ray SS, Griffith NM, Jurgensen SA, Gorelik L, Forrestal F, Sandrock AW, E Goelz S. "Assessment of JC virus DNA in blood and urine from natalizumab-treated patients." Annals of neurology.. 2010 Sep; 68(3):304-10.

Herrmann DN, O'Connor AB, Schwid SR, Da Y, Goodman AD, Rafferty J, Donahue S, Dworkin RH. "Broadening the spectrum of controls for skin biopsy in painful neuropathies." Muscle & nerve.. 2010 Sep; 42(3):436-8.

Goodman AD, Hyland M. "Dalfampridine in multiple sclerosis." Drugs of today.. 2010 Sep; 46(9):635-9.

Kister I, Chamot E, Bacon JH, Niewczyk PM, De Guzman RA, Apatoff B, Coyle P, Goodman AD, Gottesman M, Granger C, Jubelt B, Krupp L, Lenihan M, Lublin F, Mihai C, Miller A, Munschauer FE, Perel AB, Teter BE, Weinstock-Guttman B, Zivadinov R, Herbert J. "Rapid disease course in African Americans with multiple sclerosis." Neurology.. 2010 Jul 20; 75(3):217-23.

Ford C, Goodman AD, Johnson K, Kachuck N, Lindsey JW, Lisak R, Luzzio C, Myers L, Panitch H, Preiningerova J, Pruitt A, Rose J, Rus H, Wolinsky J. "Continuous long-term immunomodulatory therapy in relapsing multiple sclerosis: results from the 15-year analysis of the US prospective open-label study of glatiramer acetate." Multiple sclerosis : clinical and laboratory research.. 2010 Mar; 16(3):342-50. Epub 2010 Jan 27.

Mehta LR, McDermott MP, Goodman AD, Schwid SR. "A randomized trial of memantine as treatment for spasticity in multiple sclerosis." Multiple sclerosis : clinical and laboratory research.. 2010 Feb; 16(2):248-51. Epub 2009 Dec 22.

Goodman AD, Brown TR, Krupp LB, Schapiro RT, Schwid SR, Cohen R, Marinucci LN, Blight AR, . "Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial." Lancet.. 2009 Feb 28; 373(9665):732-8.

Goodman, AD; Rossman, H; Bar-Or, A; Miller, A; Miller, DH; Schmierer, K; Lublin, F; Khan, O; Bormann, NM; Yang, M; Panzara, MA; Sandrock, AW; GLANCE Investigators. "GLANCE: results of a phase 2, randomized, double-blind, placebo-controlled study." Neurology. 2009; 3(72(9)): 806-12.

Goodman AD; Brown TR; Drupp LB; Schapiro RT; Schwid SR; Cohen R; Marinucci LN; Blight AR; Fampridine MS-F203 Investigators. "Sustained-release oral fampridine in multiple sclerosis: a randomized double-blind, controlled trial." Lancet. 2009; 28(373): 697-8.

Goodman AD, Brown TR, Cohen JA, Krupp LB, Schapiro R, Schwid SR, Cohen R, Marinucci LN, Blight AR, . "Dose comparison trial of sustained-release fampridine in multiple sclerosis." Neurology.. 2008 Oct 7; 71(15):1134-41. Epub 2008 Jul 30.

Mehta LR, Samuelsson MK, Kleiner AK, Goodman AD, Anolik JH, Looney RJ, Schwid SR. "Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome." Multiple sclerosis : clinical and laboratory research.. 2008 Apr; 14(3):425-7. Epub 2008 Jan 21.

Mehta LR; Smauelsson MK; Kleiner AK; Goodman AD; Anolik JA; Loney JR and Schwid SR. "Neuromyelitis optica spectrum disorder in a patient with Ssstemic lupus erythematosus and anti-phospholipid antibody syndrome." Multiple Sclerosis. 2008; 14(3): 425-427.

Mehta, LR and Goodman AD. "Disease Modifying Therapies." Continuum: Lifelong Learning in Neurology. 2008; 13(5): 144-80.

Schwid SR, Goodman AD, Weinstein A, McDermott MP, Johnson KP, . "Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial." Journal of the neurological sciences.. 2007 Apr 15; 255(1-2):57-63. Epub 2007 Feb 28.

Cohen JA, Rovaris M, Goodman AD, Ladkani D, Wynn D, Filippi M, . "Randomized, double-blind, dose-comparison study of glatiramer acetate in relapsing-remitting MS." Neurology.. 2007 Mar 20; 68(12):939-44.

Goodman, AD.; Cohen, JA.; Cross, A. "Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study." Multiple Sclerosis. 2007; 2: 135-142.

Giovannoni G, Goodman A. "Neutralizing anti-IFN-beta antibodies: how much more evidence do we need to use them in practice?" Neurology.. 2005 Jul 12; 65(1):6-8.

Vollmer TL, Phillips JT, Goodman AD, Agius MA, Libonati MA, Giacchino JL, Grundy JS. "An open-label safety and drug interaction study of natalizumab (Antegren) in combination with interferon-beta (Avonex) in patients with multiple sclerosis." Multiple sclerosis : clinical and laboratory research.. 2004 Oct; 10(5):511-20.

O'Connor PW, Goodman A, Willmer-Hulme AJ, Libonati MA, Metz L, Murray RS, Sheremata WA, Vollmer TL, Stone LA, . "Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects." Neurology.. 2004 Jun 8; 62(11):2038-43.

Johnson KP, Brooks BR, Ford CC, Goodman AD, Lisak RP, Myers LW, Pruitt AA, Rizzo MA, Rose JW, Weiner LP, Wolinsky JS. "Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial." Multiple sclerosis : clinical and laboratory research.. 2003 Dec; 9(6):585-91.

Schwid SR, Tyler CM, Scheid EA, Weinstein A, Goodman AD, McDermott MP. "Cognitive fatigue during a test requiring sustained attention: a pilot study." Multiple sclerosis : clinical and laboratory research.. 2003 Oct; 9(5):503-8.

Weinstock-Guttman B, Jacobs LD, Brownscheidle CM, Baier M, Rea DF, Apatoff BR, Blitz KM, Coyle PK, Frontera AT, Goodman AD, Gottesman MH, Herbert J, Holub R, Lava NS, Lenihan M, Lusins J, Mihai C, Miller AE, Perel AB, Snyder DH, Bakshi R, Granger CV, Greenberg SJ, Jubelt B, Krupp L, Munschauer FE, Rubin D, Schwid S, Smiroldo J, . "Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium." Multiple sclerosis : clinical and laboratory research.. 2003 Jun; 9(3):293-8.

Ashton EA, Takahashi C, Berg MJ, Goodman A, Totterman S, Ekholm S. "Accuracy and reproducibility of manual and semiautomated quantification of MS lesions by MRI." Journal of magnetic resonance imaging : JMRI.. 2003 Mar; 17(3):300-8.

Goodman, A.; Mock, D.; Powers, J.; Baker, J.; Blumberg, B. "Human Herpesvirus 6 Genome and Antigen in Acute Multiple Sclerosis Lesions." J Infectious Diseases. 2003; 187(9): 1365-1376.

Schwid, SR.; Goodman, AD. "New research on the effect of temperature on MS symptoms." MS Quarterly Report. 2003; 22: 12-16.

Calabresi PA, Austin H, Racke MK, Goodman A, Choyke P, Maloni H, McFarland HF. "Impaired renal function in progressive multiple sclerosis." Neurology.. 2002 Dec 10; 59(11):1799-801.

Schwid SR, Goodman AD, McDermott MP, Bever CF, Cook SD. "Quantitative functional measures in MS: what is a reliable change?" Neurology.. 2002 Apr 23; 58(8):1294-6.

Goodman AD, Miller DH. "Infections and MS: clinical trials move to center stage." Neurology.. 2002 Jan 8; 58(1):7-8.

Goodman, AD. "Infections and Vaccinations in MS: Causative Role?". MS Quarterly Report. 2002; 21(2): 12-15.

Cohen, JA.; Cutter, GR.; Fischer, JS.; Goodman, AD.; (overall study co-PI and publication committee); et al. "Benefit of interferon ?-1a on MSFC progression in secondary progressive MS." Neurology. 2002; 9: 679-687.

Schwid, SR.; Covington, M.; Segal, BM.; Goodman, AD.(corresponding author). "Fatigue in multiple sclerosis: current understanding and future directions." J Rehabil Res Devel. 2002; 39: 211-224.

Ito M, Blumberg BM, Mock DJ, Goodman AD, Moser AB, Moser HW, Smith KD, Powers JM. "Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation." Journal of neuropathology and experimental neurology.. 2001 Oct; 60(10):1004-19.

. "Interferon beta-1a for optic neuritis patients at high risk for multiple sclerosis." American journal of ophthalmology.. 2001 Oct; 132(4):463-71.

Cohen JA, Cutter GR, Fischer JS, Goodman AD, Heidenreich FR, Jak AJ, Kniker JE, Kooijmans MF, Lull JM, Sandrock AW, Simon JH, Simonian NA, Whitaker JN. "Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial." Archives of neurology.. 2001 Jun; 58(6):961-7.

Wolinsky JS, Narayana PA, Johnson KP, . "United States open-label glatiramer acetate extension trial for relapsing multiple sclerosis: MRI and clinical correlates. Multiple Sclerosis Study Group and the MRI Analysis Center." Multiple sclerosis : clinical and laboratory research.. 2001 Feb; 7(1):33-41.

Cook, SD.; Quinless, JR.; Jotkowitz, A.; Beaton, P., The Neutralizing Antibody Study Group (Goodman, AD, Site P.I.). "Serum IFN neutralizing antibodies and neopterin levels in a cross-section of MS patients." Neurology. 2001; 57(6): 1080-1084.

Schwid SR, Goodman AD, Apatoff BR, Coyle PK, Jacobs LD, Krupp LB, Miller AE, Wende KE, Brownscheidle CM, New York State Multiple Sclero . "Are quantitative functional measures more sensitive to worsening MS than traditional measures?" Neurology.. 2000 Dec 26; 55(12):1901-3.

Ito M, Baker JV, Mock DJ, Goodman AD, Blumberg BM, Shrier DA, Powers JM. "Human herpesvirus 6-meningoencephalitis in an HIV patient with progressive multifocal leukoencephalopathy." Acta neuropathologica.. 2000 Sep; 100(3):337-41.

Johnson KP, Brooks BR, Ford CC, Goodman A, Guarnaccia J, Lisak RP, Myers LW, Panitch HS, Pruitt A, Rose JW, Kachuck N, Wolinsky JS. "Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group." Multiple sclerosis : clinical and laboratory research.. 2000 Aug; 6(4):255-66.

Wolinsky JS, Narayana PA, Noseworthy JH, Lublin FD, Whitaker JN, Linde A, Gjörstrup P, Sullivan HC. "Linomide in relapsing and secondary progressive MS: part II: MRI results. MRI Analysis Center of the University of Texas-Houston, Health Science Center, and the North American Linomide Investigators." Neurology.. 2000 May 9; 54(9):1734-41.

Blumberg, B.; Mock, D.; Powers, J.; Chen, B.; Assouline, J.; Goodman, A.(corresponding author). "The HHV6 paradox: Ubiquitous commensal or insidious pathogen?". J Clinical Virol. 2000; 16: 159-178.

Noseworthy, JH.; Wolinsky, JS.; Lublin, FD.; (Goodman, AD.-site PI). "Linomide in relapsing and secondary progressive multiple sclerosis. I. Trial design and clinical results." Neurology. 2000; 122: 871-882.

Jacobs, LR.; Beck, RW.; Simon, JH.; et al (A. Goodman, site-PI). "Intramuscular interferon Beta-1a therapy initiated during a first demyelinating event in multiple sclerosis." NEJM. 2000; 343: 989-994.

Jacobs LD, Wende KE, Brownscheidle CM, Apatoff B, Coyle PK, Goodman A, Gottesman MH, Granger CV, Greenberg SJ, Herbert J, Krupp L, Lava NS, Mihai C, Miller AE, Perel A, Smith CR, Snyder DH. "A profile of multiple sclerosis: the New York State Multiple Sclerosis Consortium." Multiple sclerosis : clinical and laboratory research.. 1999 Oct; 5(5):369-76.

Schwid SR, Thornton CA, Pandya S, Manzur KL, Sanjak M, Petrie MD, McDermott MP, Goodman AD. "Quantitative assessment of motor fatigue and strength in MS." Neurology.. 1999 Sep 11; 53(4):743-50.

Weinstein A, Schwid SR, Schiffer RB, McDermott MP, Giang DW, Goodman AD, Schwid SI. "Neuropsychologic status in multiple sclerosis after treatment with glatiramer." Archives of neurology.. 1999 Mar; 56(3):319-24.

Rudick, RA.; Goodman, AD.; Herndon, RM.; Panitch, HS. "Selecting Relapsing Remitting Multiple Sclerosis Patients for Treatment: The Case for Early Treatment." J Neuroimmunology. 1999; 98(1): 22-28.

Mock, DJ.; Powers, JM.; Goodman, AD.; et al. "Association of human herpesvirus 6 with the demyelinative lesions of progressive multifocal leukoencephalopathy." J NeuroVirology. 1999; 5: 363-373.

Goodman AD; Mock DJ; Powers JM; Baker JV; Blumberg B;. "Correlation of human herpesvirus 6 p41 and p 101 expression and oligodendroglial cell death in progressive multifocal leukoencephalopathy". Annals of Neurology. 1999; 46(3): 488.

Goodman AD; Mock D; Powers J et al. "Association of human herpes virus 6 (HHV6) with demyelinating lesions." J Neuroimmunology. 1998; 90(1): 66.

Schwid SR, Goodman AD, Mattson DH, Mihai C, Donohoe KM, Petrie MD, Scheid EA, Dudman JT, McDermott MP. "The measurement of ambulatory impairment in multiple sclerosis." Neurology.. 1997 Nov; 49(5):1419-24.

Schwid SR, Goodman AD, Mattson DH. "Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b." Archives of neurology.. 1997 Sep; 54(9):1169-90.

Schwid SR, Petrie MD, McDermott MP, Tierney DS, Mason DH, Goodman AD. "Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis." Neurology.. 1997 Apr; 48(4):817-21.

Schwid SR, Goodman AD, Puzas JE, McDermott MP, Mattson DH. "Sporadic corticosteroid pulses and osteoporosis in multiple sclerosis." Archives of neurology.. 1996 Aug; 53(8):753-7.

Giang, DW.; Goodman, AD. (study PI); Schiffer, RB.; Mattson, DH.; Cohen, N.; Ader, R. "Can immunomodulatory effects of cyclophosphamide be conditioned in humans?". Journal of Neuropsychiatry and Clinical Neuroscience. 1996; 8: 194-201.

Barned S, Goodman AD, Mattson DH. "Frequency of anti-nuclear antibodies in multiple sclerosis." Neurology.. 1995 Feb; 45(2):384-5.

Giang DW, Grow VM, Mooney C, Mushlin AI, Goodman AD, Mattson DH, Schiffer RB. "Clinical diagnosis of multiple sclerosis. The impact of magnetic resonance imaging and ancillary testing. Rochester-Toronto Magnetic Resonance Study Group." Archives of neurology.. 1994 Jan; 51(1):61-6.

Schiffer RB, Giang DW, Mushlin A, Ketonen L, Joy S, Kido D, Goodman AD, Mattson DH, Mooney C. "Perils and pitfalls of magnetic resonance imaging in the diagnosis of multiple sclerosis. The Rochester-Toronto MRI Study Group." Journal of neuroimaging : official journal of the American Society of Neuroimaging.. 1993 Apr; 3(2):81-8.

Mushlin AI, Detsky AS, Phelps CE, O'Connor PW, Kido DK, Kucharczyk W, Giang DW, Mooney C, Tansey CM, Hall WJ. "The accuracy of magnetic resonance imaging in patients with suspected multiple sclerosis. The Rochester-Toronto Magnetic Resonance Imaging Study Group." JAMA.. 1993 269(24):3146-51.

"Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. The Multiple Sclerosis Study Group." Annals of neurology.. 1990 Jun; 27(6):591-605.

Goodman AD, Jacobson S, McFarland HF. "Virus-specific cytotoxic T lymphocytes in multiple sclerosis: a normal mumps virus response adds support for a distinct impairment in the measles virus response." Journal of neuroimmunology.. 1989 May; 22(3):201-9.

McFarland, HF.; Goodman, AD.; Jacobson, S. "Virus specific cytotoxic T lymphocytes in multiple sclerosis." Annals of NY Acad. Med. 1988; 532: 273-279.

Gudesblatt M, Goodman AD, Rubenstein AE, Bender AN, Choi HS. "Autonomic neuropathy associated with autoimmune disease." Neurology.. 1985 Feb; 35(2):261-4.

Stiller, J.; Goodman, AD.; Kamhi, L.; Bender, MB. "Neurosarcoidosis presenting as major depression." Neurol Neurosurg Psych. 1984; 47: 1050.